These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 32093678)

  • 1. CD4
    Song CB; Zhang LL; Wu X; Fu YJ; Jiang YJ; Shang H; Zhang ZN
    J Transl Med; 2020 Feb; 18(1):95. PubMed ID: 32093678
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Atlas of the HIV-1 Reservoir in Peripheral CD4 T Cells of Individuals on Successful Antiretroviral Therapy.
    Gálvez C; Grau-Expósito J; Urrea V; Clotet B; Falcó V; Buzón MJ; Martinez-Picado J
    mBio; 2021 Dec; 12(6):e0307821. PubMed ID: 34844430
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Peripheral T Follicular Helper Cells Are the Major HIV Reservoir within Central Memory CD4 T Cells in Peripheral Blood from Chronically HIV-Infected Individuals on Combination Antiretroviral Therapy.
    Pallikkuth S; Sharkey M; Babic DZ; Gupta S; Stone GW; Fischl MA; Stevenson M; Pahwa S
    J Virol; 2015 Dec; 90(6):2718-28. PubMed ID: 26676775
    [TBL] [Abstract][Full Text] [Related]  

  • 4. HIV DNA subspecies persist in both activated and resting memory CD4+ T cells during antiretroviral therapy.
    Murray JM; Zaunders JJ; McBride KL; Xu Y; Bailey M; Suzuki K; Cooper DA; Emery S; Kelleher AD; Koelsch KK;
    J Virol; 2014 Mar; 88(6):3516-26. PubMed ID: 24403590
    [TBL] [Abstract][Full Text] [Related]  

  • 5. HIV persistence in mucosal CD4+ T cells within the lungs of adults receiving long-term suppressive antiretroviral therapy.
    Costiniuk CT; Salahuddin S; Farnos O; Olivenstein R; Pagliuzza A; Orlova M; Schurr E; De Castro C; Bourbeau J; Routy JP; Ancuta P; Chomont N; Jenabian MA
    AIDS; 2018 Oct; 32(16):2279-2289. PubMed ID: 30102653
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dysfunctional phenotypes of CD4+ and CD8+ T cells are comparable in patients initiating ART during early or chronic HIV-1 infection.
    Amu S; Lantto Graham R; Bekele Y; Nasi A; Bengtsson C; Rethi B; Sorial S; Meini G; Zazzi M; Hejdeman B; Chiodi F
    Medicine (Baltimore); 2016 Jun; 95(23):e3738. PubMed ID: 27281071
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CD32 is expressed on cells with transcriptionally active HIV but does not enrich for HIV DNA in resting T cells.
    Abdel-Mohsen M; Kuri-Cervantes L; Grau-Exposito J; Spivak AM; Nell RA; Tomescu C; Vadrevu SK; Giron LB; Serra-Peinado C; Genescà M; Castellví J; Wu G; Del Rio Estrada PM; González-Navarro M; Lynn K; King CT; Vemula S; Cox K; Wan Y; Li Q; Mounzer K; Kostman J; Frank I; Paiardini M; Hazuda D; Reyes-Terán G; Richman D; Howell B; Tebas P; Martinez-Picado J; Planelles V; Buzon MJ; Betts MR; Montaner LJ
    Sci Transl Med; 2018 Apr; 10(437):. PubMed ID: 29669853
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Persistence of integrated HIV DNA in CXCR3 + CCR6 + memory CD4+ T cells in HIV-infected individuals on antiretroviral therapy.
    Khoury G; Anderson JL; Fromentin R; Hartogenesis W; Smith MZ; Bacchetti P; Hecht FM; Chomont N; Cameron PU; Deeks SG; Lewin SR
    AIDS; 2016 Jun; 30(10):1511-20. PubMed ID: 26807971
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Establishment and Reversal of HIV-1 Latency in Naive and Central Memory CD4+ T Cells In Vitro.
    Zerbato JM; Serrao E; Lenzi G; Kim B; Ambrose Z; Watkins SC; Engelman AN; Sluis-Cremer N
    J Virol; 2016 Sep; 90(18):8059-73. PubMed ID: 27356901
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immune activation and exhaustion marker expression on T-cell subsets in ART-treated adolescents and young adults with perinatal HIV-1 infection as correlates of viral persistence.
    Huang Y; Dhummakupt A; Khetan P; Nilles T; Zhou W; Mudvari P; Szewczyk J; Chen YH; Boritz E; Ji H; Agwu A; Persaud D
    Front Immunol; 2023; 14():1007626. PubMed ID: 37033916
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CD4+ T Cells Expressing PD-1, TIGIT and LAG-3 Contribute to HIV Persistence during ART.
    Fromentin R; Bakeman W; Lawani MB; Khoury G; Hartogensis W; DaFonseca S; Killian M; Epling L; Hoh R; Sinclair E; Hecht FM; Bacchetti P; Deeks SG; Lewin SR; Sékaly RP; Chomont N
    PLoS Pathog; 2016 Jul; 12(7):e1005761. PubMed ID: 27415008
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Selective increase of activation antigens HLA-DR and CD38 on CD4+ CD45RO+ T lymphocytes during HIV-1 infection.
    Kestens L; Vanham G; Vereecken C; Vandenbruaene M; Vercauteren G; Colebunders RL; Gigase PL
    Clin Exp Immunol; 1994 Mar; 95(3):436-41. PubMed ID: 7907956
    [TBL] [Abstract][Full Text] [Related]  

  • 13. HIV-1-infected children on HAART: immunologic features of three different levels of viral suppression.
    Zaccarelli-Filho CA; Ono E; Machado DM; Brunialti M; Succi RC; Salomão R; Kallás EG; de Moraes-Pinto MI
    Cytometry B Clin Cytom; 2007 Jan; 72(1):14-21. PubMed ID: 17041945
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Virologic and immunologic effects of adding maraviroc to suppressive antiretroviral therapy in individuals with suboptimal CD4+ T-cell recovery.
    Cillo AR; Hilldorfer BB; Lalama CM; McKinnon JE; Coombs RW; Tenorio AR; Fox L; Gandhi RT; Ribaudo H; Currier JS; Gulick RM; Wilkin TJ; Mellors JW
    AIDS; 2015 Oct; 29(16):2121-9. PubMed ID: 26544577
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Innate and adaptive abnormalities in youth with vertically acquired HIV through a multicentre cohort in Spain.
    Carrasco I; Tarancon-Diez L; Vázquez-Alejo E; Jiménez de Ory S; Sainz T; Apilanez M; Epalza C; Guillén S; Tomás Ramos J; Díez C; Bernardino JI; Iribarren JA; Zamora A; Muñoz-Fernández MÁ; Navarro ML;
    J Int AIDS Soc; 2021 Oct; 24(10):e25804. PubMed ID: 34672108
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impaired Th17 polarization of phenotypically naive CD4(+) T-cells during chronic HIV-1 infection and potential restoration with early ART.
    DaFonseca S; Niessl J; Pouvreau S; Wacleche VS; Gosselin A; Cleret-Buhot A; Bernard N; Tremblay C; Jenabian MA; Routy JP; Ancuta P
    Retrovirology; 2015 Apr; 12():38. PubMed ID: 25924895
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Partial recovery of senescence and differentiation disturbances in CD8
    Eberhard JM; Ahmad F; Hong HS; Bhatnagar N; Keudel P; Schulze Zur Wiesch J; Schmidt RE; Meyer-Olson D
    Clin Exp Immunol; 2016 Nov; 186(2):227-238. PubMed ID: 27377704
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Analytical antiretroviral therapy interruption does not irreversibly change preinterruption levels of cellular HIV.
    Papasavvas E; Lada SM; Joseph J; Yin X; Liu Q; Azzoni L; Mounzer K; Kostman JR; Richman D; Montaner LJ
    AIDS; 2018 Aug; 32(13):1763-1772. PubMed ID: 30045057
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CD38+CD8+ T-cells negatively correlate with CD4 central memory cells in virally suppressed HIV-1-infected individuals.
    Kolber MA
    AIDS; 2008 Oct; 22(15):1937-41. PubMed ID: 18784457
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Determinants of CD4+ T cell recovery during suppressive antiretroviral therapy: association of immune activation, T cell maturation markers, and cellular HIV-1 DNA.
    Goicoechea M; Smith DM; Liu L; May S; Tenorio AR; Ignacio CC; Landay A; Haubrich R
    J Infect Dis; 2006 Jul; 194(1):29-37. PubMed ID: 16741879
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.